Details for New Drug Application (NDA): 205724
✉ Email this page to a colleague
NDA 205724 describes ITRACONAZOLE, which is a drug marketed by Accord Hlthcare, Alembic, Alkem Labs Ltd, Amneal Pharms, Jubilant Generics, Mylan Pharms Inc, Rising, Sandoz, Strides Pharma, Torrent, Zydus Pharms, Annora Pharma, and Apotex, and is included in fourteen NDAs. It is available from fifteen suppliers. Additional details are available on the ITRACONAZOLE profile page.
The generic ingredient in ITRACONAZOLE is itraconazole. There are fifteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the itraconazole profile page.
The generic ingredient in ITRACONAZOLE is itraconazole. There are fifteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the itraconazole profile page.
Summary for 205724
| Tradename: | ITRACONAZOLE |
| Applicant: | Rising |
| Ingredient: | itraconazole |
| Patents: | 0 |
Suppliers and Packaging for NDA: 205724
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ITRACONAZOLE | itraconazole | CAPSULE;ORAL | 205724 | ANDA | Rising Pharma Holdings, Inc. | 16571-245 | 16571-245-03 | 30 CAPSULE in 1 BOTTLE (16571-245-03) |
| ITRACONAZOLE | itraconazole | CAPSULE;ORAL | 205724 | ANDA | Par Pharmaceutical, Inc. | 49884-239 | 49884-239-11 | 30 CAPSULE in 1 BOTTLE (49884-239-11) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
| Approval Date: | Dec 13, 2016 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
